Sign In
Buy EYPT
$12.34
-0.190 (-1.52%)
At Close: Jun 03, 2026
EyePoint Pharmaceuticals, Inc. (EYPT) Q1 2023 Earnings Call Transcript
11:48pm, Wednesday, 03'rd May 2023
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT ) Q1 2023 Results Conference Call May 3, 2023 8:30 AM ET Company Participants George Elston - Chief Financial Officer Nancy Lurker - Chief Executive Officer
Strength Seen in EyePoint Pharmaceuticals (EYPT): Can Its 9.6% Jump Turn into More Strength?
05:20am, Thursday, 20'th Apr 2023
EyePoint Pharmaceuticals (EYPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further stre
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
08:00am, Monday, 27'th Feb 2023
WATERTOWN, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients w
EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on March 2, 2023
07:00am, Thursday, 23'rd Feb 2023
WATERTOWN, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the
5 Penny Stocks To Buy According To Analysts, Targets Up To 992%
01:33pm, Monday, 14'th Nov 2022
Analysts say these are penny stocks to buy. Do you agree?
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
08:00am, Monday, 07'th Nov 2022
WATERTOWN, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the live
EyePoint Pharmaceuticals, Inc. (EYPT) Q3 2022 Earnings Call Transcript
01:58pm, Wednesday, 02'nd Nov 2022
Start Time: 08:30 January 1, 0000 9:13 AM ET EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT ) Q3 2022 Earnings Conference Call November 02, 2022, 08:30 AM ET Company Participants Nancy Lurker - President
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates
09:48am, Wednesday, 02'nd Nov 2022
EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of 30% and 0.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc
EyePoint Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 2, 2022
07:00am, Wednesday, 26'th Oct 2022
WATERTOWN, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the live
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
04:01pm, Tuesday, 06'th Sep 2022
WATERTOWN, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the liv
EyePoint Pharmaceuticals: Key Player In The Long-Acting Wet AMD Space
12:17am, Tuesday, 30'th Aug 2022
Shares have lost 15% year to date. Durasert technology has been extensively validated and administered to over 80,000 patient eyes.
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q2 2022 Results - Earnings Call Transcript
03:05pm, Wednesday, 03'rd Aug 2022
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT ) Q2 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants George Elston - Chief Financial Officer Nancy Lurker - President and Chief
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Tops Revenue Estimates
09:47am, Wednesday, 03'rd Aug 2022
EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of 8.77% and 2.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
07:00am, Tuesday, 02'nd Aug 2022
WATERTOWN, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the live
EyePoint Pharmaceuticals (EYPT) Soars 21.6%: Is Further Upside Left in the Stock?
06:13am, Monday, 18'th Jul 2022
EyePoint Pharmaceuticals (EYPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further stre
